Skip to main content

Advertisement

Log in

Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to evaluate the expression profiles of the relevant selectins and PDGF in schistosomiasis-associated pulmonary hypertension.

Methodology

Patients with three distinct clinical profiles were enrolled in the study: IPAH(n = 11), schistosomiasis-associated PH (Sch-PH))(n = 13), and schistosomiasis without PH (Sch) (n = 13). Healthy volunteers, were recruited as a control group(n = 13). Echocardiography was performed in all groups, and the PH patients underwent right heart catheterization. Plasma soluble adhesion molecules E- and P-Selectin, PDGF-AB, PDGF-BB were determined by ELISA.

Results

E-selectin was significantly increased in the IPAH group compared with the other groups [the control, Sch + PH and Sch groups) (p < 0.001) (Fig. 2)]. P-selectin was lower in Sch (20.2 + 8.9 × 103 pg/mL) as compared to the control, (43 16.8 × 103 pg/mL), IPAH (35.8 7.8 × 103 pg/mL), and Sch + PH (36.8 ± 15.7 × 103 pg/mL) (p = 0.005) groups. Serum PDGF-BB levels were higher in the control group (8.9 ± 4.8 × 103 pg/mL) compared with the IPAH (3.7 ± 2.17 × 103 pg/mL), Sch + PH (5.2 ± 3.7 × 103 pg/mL) and Sch (2.4 ± 1.7 × 103 pg/mL) groups (p < 0.05). PDGF-AB levels were also higher in the control group (25.6 ± 8.6 × 103 pg/mL), compared with the other three groups, being the Sch group the one with lower serum levels of this marker (11.4 ± 8.6 × 103 pg/mL) (p = 0.006).

Conclusions

In conclusion, vascular inflammation in schistosomiasis, with or without PH, is different from IPAH suggesting distinct pathophysiological mechanisms associated with the development of pulmonary hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chin KM, Rubin LJ (2008) Pulmonary arterial hypertension. J Am Coll Cardiol 51:1527–1538

    Article  PubMed  Google Scholar 

  2. Badesch DB, Champion HC, Sanchez MAG, Hoeper MM, Loyd JE et al (2009) Diagnosis and assessment of pulmonary hypertension. J Am Coll Cardiol 54(1):255–266

    Article  Google Scholar 

  3. Humbert M (2008) Update in pulmonary arterial hypertension 2007. Am J Respir Crit Care Med 177:574–579. doi:10.1164/rccm.200801-029UP

    Article  CAS  PubMed  Google Scholar 

  4. Souza R, Fernandes CJ, Jardim CV (2009) Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension). Semin Respir Crit Care Med 30(4):448–457. doi:10.1055/s-0029-1233314

    Article  PubMed  Google Scholar 

  5. Lapa MS, Dias B, Jardim C, Fernandes CJC, Dourado P, Figueiredo M, Farias A, Tutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518–1523

    Article  PubMed  Google Scholar 

  6. Butrous G, Ghofrani HA, Grimminger F (2008) Pulmonary vascular disease in the developing world. Circulation 118:1758–1766

    Article  PubMed  Google Scholar 

  7. Conceição MJ, Borges-Pereira J, Coura JR (2007) A thirty years follow-up study on Schistosomiasis mansoni in a community of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 102(8):1007–1009

    Article  PubMed  Google Scholar 

  8. Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AAM et al (2000) Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77:101–109

    Article  CAS  PubMed  Google Scholar 

  9. Fernandes CJCS, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715–720

    Article  Google Scholar 

  10. Cahill PARE, Sitzmann JV (2001) Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 89:273–293 (2001)

    Article  CAS  PubMed  Google Scholar 

  11. Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77:111–131

    Article  CAS  PubMed  Google Scholar 

  12. Cichoz-Lach HCK, Stomka M, Kasztelan-Szczerbinska B (2008) Pathophysiology of portal hypertension. J Physiol Pharmacol 59(Suppl 2):231–238

    Google Scholar 

  13. Cella G, Belloto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226–1230

    Article  CAS  PubMed  Google Scholar 

  14. Morrel NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX-Y, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):s20–s31. doi:10.1016/j.jacc.2009.04.018

    Article  Google Scholar 

  15. Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):20s–29s

    Article  PubMed  Google Scholar 

  16. Barrier M, Meloche J, Jacob MH, Courboulin A, Provencher S, Bonnet S (2012) Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci 69(17):2805–2831. doi:10.1007/s00018-012-0950-4

    Article  CAS  PubMed  Google Scholar 

  17. Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165

    Article  PubMed  Google Scholar 

  18. Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2007) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81–88. doi:10.1164/rccm.200707-1037OC07-1037OC

    Article  Google Scholar 

  19. Trottein F, Nutten S, Angeli V, Delerive P et al (1999) Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with NF-kappaB pathway. Eur J Immunol 29:3691–3701

    Article  CAS  PubMed  Google Scholar 

  20. Soares S, Rodrigues-Junior V, Silva DTN, Moraes-Souza H (2007) Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. schistosomiasis. Rev Soc Bras Med Trop 40(3):321–325

    Article  PubMed  Google Scholar 

  21. Vezozzo DCP, Farias AQ, Cerri GG, da Silva LC, Carrilho FJ (2006) Assessment of portal hemodynamics by doppler ultrasound and of liver morphology in the hepatospleinc and hepatointestinal forms of Schistosomiasis mansoni. Dig Dis Sci 51:1413–1419

    Article  PubMed  Google Scholar 

  22. Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M (1992) A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. Acta Trop 51:15–28

    Article  CAS  PubMed  Google Scholar 

  23. Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406

    Article  PubMed  Google Scholar 

  24. Simmonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliot CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54

    Article  Google Scholar 

  25. Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R (2005) Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vasc Pharmacol 43(3):143–147. doi:10.1016/j.vph.2005.05.004

    Article  CAS  Google Scholar 

  26. Rather LJ, Virchow RLK, Schwalbe J (1990) A commentary on the medical writings of Rudolf Virchow: based on Schwalbe’s Virchow-Bibliographie, 1843–1901. Norman Publishing

  27. Witters P, Freson K, Verslype C, Peerkink K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D (2008) Review article: blood platelet count number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27:1017–1029

    Article  CAS  PubMed  Google Scholar 

  28. Eddahibi E, Humbert M, Sediame S, Chouaid C et al (2000) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med 162:1493–1499

    Article  CAS  PubMed  Google Scholar 

  29. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276–1312

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Carlos Sérgio Rocha da Silva from Pleura Laboratory and the MECOR course instructors, especially William Volmer.

Financial support

Fundação de Amparo a Pesquisa do Estado de São Paulo - FAPESP.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Terra-Filho.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapa, M., Acencio, M.M.P., Farias, A.Q. et al. Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension. Lung 192, 981–986 (2014). https://doi.org/10.1007/s00408-014-9643-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-014-9643-0

Keywords

Navigation